Abstract: The present invention is directed to a method and means for enabling contact lens wearers to photograph their own eyes using an electronic device with a camera such as an iPhone with a macro lens, for example, Olloclip® Macro Pro Lens Set 7× lens, and a custom three-dimensional printed eyecup attachment. The eyecup attachment is designed to position the camera at a suitable and reproducible distance from the eye to ensure that the system can focus appropriately on the lens details. The eyecup attachment also serves to block stray light and diffuse the ambient lighting. In addition, the eyecup attachment ensures that the camera is held in the correct orientation while photos are being captured. The capture images are analyzed using image processing software to determine the angel of rotation of the contact lens.

Abstract: The present invention is directed to a method and means for enabling contact lens wearers to photograph their own eyes using an electronic device with a camera such as an iPhone with a macro lens, for example, Olloclip® Macro Pro Lens Set 7× lens, and a custom three-dimensional printed eyecup attachment. The eyecup attachment is designed to position the camera at a suitable and reproducible distance from the eye to ensure that the system can focus appropriately on the lens details. The eyecup attachment also serves to block stray light and diffuse the ambient lighting. In addition, the eyecup attachment ensures that the camera is held in the correct orientation while photos are being captured. The capture images are analyzed using image processing software to determine the angel of rotation of the contact lens.

Abstract: The present invention relates to ionic silicone hydrogel polymers comprising at least one pharmaceutical or nutriceutical component and displaying improved lysozyme uptake, low contact angle and reduced water soluble polymeric ammonium salt uptake.

Abstract: The present invention relates to ionic silicone hydrogel contact lenses which comprise at least one pharmaceutical or nutriceutical component and are formed from reaction mixtures comprising a mixture of slow-reacting hydrophilic monomers, including at least one slow-reacting ionic monomer, at least one silicone-containing component and at least one hydroxyl-containing component, wherein the ratio of the slow-reacting hydrophilic component half lives to the silicone-containing component half life is at least 2.

Abstract: The present invention relates to ionic silicone hydrogel polymers displaying improved thermal stability. More specifically, the present invention relates to a polymer formed from reactive components comprising at least one silicone component and at least one ionic component comprising at least one anionic group. The polymers of the present invention display good thermal stability and desirable protein uptake.

Abstract: The present invention relates to ionic silicone hydrogel polymers displaying improved thermal stability. More specifically, the present invention relates to a polymer formed from reactive components comprising at least one silicone component and at least one ionic component comprising at least one anionic group. The polymers of the present invention display good thermal stability and desirable protein uptake.

Abstract: Ophthalmic devices and methods of treating allergic conjunctivitis are disclosed herein.

Abstract: The present invention relates to a process comprising (a) dosing a reactive mixture comprising at least one crosslinkable prepolymer into a mold; (b) curing said reactive mixture to form a medical device; (c) contacting, said medical device with no more than about 500 mL of solution per medical device; and (d) incorporating, prior to or during said contacting step (c), at least one therapeutic agent.